Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q7PX35

Entry ID Method Resolution Chain Position Source
AF-Q7PX35-F1 Predicted AlphaFoldDB

No variants for Q7PX35

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q7PX35

No associated diseases with Q7PX35

No regional properties for Q7PX35

Type Name Position InterPro Accession
No domain, repeats, and functional sites for Q7PX35

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

3 GO annotations of cellular component

Name Definition
mRNA cap binding complex Any protein complex that binds to an mRNA cap at any time in the lifetime of the mRNA.
nuclear cap binding complex A conserved heterodimeric protein complex that binds to the 5' terminal cap structure m7G(5')ppp(5')N of nascent eukaryotic RNA polymerase II transcripts such as pre-mRNA and U snRNA. The consists of proteins known as CBP20 and CBP80, binds to cap structures in the nucleus, and is involved in pre-mRNA splicing, 3'-end formation, and RNA nuclear export.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

2 GO annotations of molecular function

Name Definition
mRNA binding Binding to messenger RNA (mRNA), an intermediate molecule between DNA and protein. mRNA includes UTR and coding sequences, but does not contain introns.
RNA cap binding Binding to a 7-methylguanosine (m7G) group or derivative located at the 5' end of an RNA molecule.

5 GO annotations of biological process

Name Definition
7-methylguanosine mRNA capping Addition of the 7-methylguanosine cap to the 5' end of a nascent messenger RNA transcript.
gene silencing by RNA A process in which an RNA molecule reduces expression of target genes. This can occur pre-transcriptionally by assembly of heterochromatin and prevention of transcription or co- or post-transcriptionally by targeting RNAs for degradation or by interfering with splicing or translation. This process starts once the inhibitory RNA molecule has been transcribed, and includes processing of the RNA such as cleavage, modifications, transport from the nucleus to the cytoplasm, loading onto the RISC complex, and the effect on transcription or translation.
mRNA export from nucleus The directed movement of mRNA from the nucleus to the cytoplasm.
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay The nonsense-mediated decay pathway for nuclear-transcribed mRNAs degrades mRNAs in which an amino-acid codon has changed to a nonsense codon; this prevents the translation of such mRNAs into truncated, and potentially harmful, proteins.
RNA splicing The process of removing sections of the primary RNA transcript to remove sequences not present in the mature form of the RNA and joining the remaining sections to form the mature form of the RNA.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MNRRRAYEDD GDFYGERNKK RRRVSENQEM EERLETLILR VGENSTSSLE SNLEGLVSVL
70 80 90 100 110 120
ESDLGNFRSK ILRILSDCPI KMPEKCTIYS TMVGLMNAKN YNFGGEFVEY MVKTFKDSLK
130 140 150 160 170 180
QCQWDAARYA LRFLADLVNC HVISTNSLLQ LLDSMVDAAN EDNVPQVRRD WYVFAVLSTL
190 200 210 220 230 240
PWVGRELYEK KESALENLLV RIEVFLNKRT KKHHNALRVW SVDAPHPQEE YLDCLWAQIR
250 260 270 280 290 300
KLRQDNWTEK HIPRPYLAFD SVLCEALQHN IPVIHPPPHQ DSFEYPMPWV VYRMFDYTDC
310 320 330 340 350 360
PPGPILPGAH SIERFLIEEH LHSIIEMHRW ERKDCAIHLL MLPYKDKIPL EYCIVEVIFA
370 380 390 400 410 420
ELFHMPTPRY LEICYGSILI ELCKQQPSKM PQVLAQATEI LFMRIDSMNT SCFDRFVNWF
430 440 450 460 470 480
SYHLSNFQFR WSWDDWDSCL LLENEHPRPK FIQEVLLKCL RFSYHDRFKE MMPEGYAKLI
490 500 510 520 530 540
PKPPVPHYKY SMEGAASLPG TATAHKLVVA IRQKCNAEDV LNELNDLPNS RDASDTDMAE
550 560 570 580 590 600
APFNPLKIDV FVQTLLNLGS KSFSHSFAAI SKFHAVFKAL AETEEAQICI LHNMFELWVD
610 620 630 640 650 660
HQQMMVVIVD KLLKVQIVEC SAVATWVFSK EMVGEFTKMY LWEILHLTIK KMNQHVTKLS
670 680 690 700 710 720
REMNEAKEKL ARTVESSSSE SEDEAASPNA QKRRKNTEGS GEKPTEEQVE RMEEKLEAAY
730 740 750 760 770 780
VDQKRLFLII FQRFIMILSE HLVKCDTDGR DYDTDWYRWT IGRLQQVFMM HHEQVQKYSS
790 800
TLESLLFTSD LDPHILDVFH QFTALRA